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Nosocomial infection is an upcoming problem in developing countries as more of high-risk preterm neonates are being saved due to increasing usage of advanced technology, 
including care practice devices [1]. Furthermore, rate of antibiotic 
resistance in pathogens causing neonatal sepsis is increasing [2]. 
Preterm infants are particularly susceptible to infections due to 
high environmental load of pathogenic organisms in developing 
countries and their skin lacks natural protective cutaneous biofilm 
vernix, which is developmentally immature, easily injured, and 
functionally compromised due to malnutrition [3,4].
Interventions that prevent morbidity during the neonatal 
period that are not centered on antibiotic use have the potential 
to be highly cost-effective and affect health far beyond neonatal 
period [5,6]. Linoleate has been shown to be most potent activator 
of peroxisome proliferator-activated receptor alpha (PPAR a), 
and its application to fetal rat skin at physiologic concentrations 
accelerates epidermal barrier development [7]. Sunflower seed 
oil with high linoleate content thus appears ideal for topical 
application in preterm neonates. Since only limited published data 
from developing countries and India are available on this subject; 
therefore, a study was planned to evaluate the effect of sunflower 
oil application on nosocomial sepsis and skin condition.
MATERIALS AND METHODS
A randomized controlled trial was conducted in the referral 
neonatal unit of a teaching hospital for 11-month period starting 
March 2015. The study was approved by the Institutional 
Ethics Committee and written informed consent was obtained 
from the mother before the enrollment. All consecutive preterm 
neonates admitted before 4 days of age with admission weight of 
1000–2000 g were included in the study. Babies with the  score for 
neonatal acute physiology II (SNAP II) [8] >77 at 2 h of admission, 
major congenital malformations, generalized skin disease, 
infective diarrhea, and on ventilator for >12 h were excluded.
The primary outcome measure was the incidence of nosocomial 
sepsis during a hospital stay or 28 days of life, whichever was 
earlier. While the secondary outcome measure was difference 
in the skin condition score at enrollment and at 5 days interval 
until discharge (Lane and Drost) [9], and the difference in weight, 
length and head circumference, and serum triglycerides levels at 
enrollment and discharge.
Based on the past 12-month admission rate in the referral 
neonatal unit with requisite inclusion and exclusion criteria, a 
convenient sample size of 80 consecutive neonates was taken. 
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All consecutive neonates admitted in the unit fulfilling the 
inclusion criteria were enrolled. Computer-generated random 
number sequence after block randomization was used for group 
allocation. Serial numbered opaque sealed envelopes were used 
for allocation to oil (n=39) and control (n=39) groups.
Baseline characteristics included age, sex, gestational age, 
weight, length, and head circumference. Antenatal risk factors 
for sepsis were elicited. Birth history included place and type of 
delivery, time to first cry, and resuscitation. Usage of care practice 
devices on neonate was also recorded. Assessment at enrollment 
and during a hospital stay for suspected sepsis included clinical 
features such as toxic appearance, cyanosis, feeble pulses, low/
high axillary temperature, skin bleed, seizures, or full fontanel. 
Lab evaluation included sepsis screen and blood culture. Lumbar 
puncture was done if sepsis screen was positive.
Following enrollment, neonates in oil group received sunflower 
oil (procured as Saffola oil from Kendriya Bhandar) application 
over entire body below neck by the principal investigator 3 times 
daily (each application for 1–2 min) for initial 7 days. The amount 
of oil used was 4 ml/kg body weight/application. During this 
period, mother (caregiver, if mother not available) was trained 
by the principal investigator in hand washing and oil application 
techniques. Subsequently, during hospital stay, mother applied 
oil 3 times daily under the supervision of principal investigator. 
Neonates in control group were handled and cared in similar 
manner except oil application. The intervention could not be 
blinded due to operational reasons. Every effort was made to 
prevent contamination between randomized groups and mothers 
were physically separated as far as possible. Cultures of oil 
samples were taken every 7–10 days to check for the colonization. 
The temperature was recorded before and after the intervention to 
prevent hypothermia. Oil application was temporarily discontinued 
if neonate developed shock requiring inotropic support or ventilated 
or had apneas requiring continuous positive airway pressure.
All neonates were observed daily for the clinical feature of 
sepsis, if present, sepsis screen, and blood cultures were done. Skin 
surface culture was taken from axilla and abdomen (1 cm radius area 
around umbilicus) at enrollment and every 5 days to detect surface 
colonization. Assessment of skin condition over abdomen, and 
dorsum of hand and foot was done at enrollment and 5 days interval 
during the study period by the principal investigator. The enrolled 
neonates were followed up after 3–5 days of discharge by evaluating 
clinical features and/or sepsis screen to detect any incubating 
infections at the time of discharge. All neonates with diagnosed 
sepsis were started on antibiotics according to unit protocol.
Statistical analysis was done using Epi-info 6 software, by 
both intention to treat and per-protocol (minimum 4 days of 
intervention) methods; p<0.05 was considered significant.
RESULTS
During study period 1339 neonates were admitted in referral 
neonatal unit and total 78 consecutive neonates satisfying 
inclusion criteria were enrolled. Of these, 70 neonates completed 
trial defined as an intervention or hospital stay of ≥4 days after 
enrollment (Fig. 1).
Table 1 depicts the baseline characteristics of study subjects. 
While 53.8%, 15.4%, and 30.8% neonates in oil group were 
late, moderate, and very preterm, respectively, the numbers 
of these babies in the control group were 59%, 18%, and 23%, 
respectively. Further, the number of low birth weight (LBW) and 
very LBW (VLBW) babies in oil group was 38.5% and 61.5% 
Allocation
Oil group (n=39)
Excluded (n=85)
Surgical malformation (n=26)
Skin disease (n=3)
Infective diarrhea (n=4)
Ventilated (n=51)
No consent (n=1)
Total admissions in referral neonatal unit (n=1339)
Assessed for eligibility (n=163)
Randomized (n=78)
Control group (n=39)
Follow up
Intention to treat (n=39)
Per protocol (n=33)  
Intention to treat (n=39)
Per protocol (n=37) 
Analysis
Enrollment
Intervention <4
days (n=6)
Hospital stay <4
days (n=2)
•
••
•
Figure 1: Study flowchart
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while in control group, 56.4% and 43.6% of neonates were LBW 
and VLBW, respectively. Almost 70% of babies in both groups 
were small for gestational age [10]. While 17 mothers in oil group 
had any one or more of the risk factors of sepsis, 11 mothers 
in control group had one or more risk factor. During the study 
period all 39 babies in oil group and 38 of 39 in control group had 
intravenous cannula. Umbilical catheter was placed in four babies 
in oil group while none in control group. Eight babies each in 
both groups had endotracheal tube inserted. Device days, defined 
as sum of days for which each device was used in a neonate, were 
(median [range]) 6 (1, 31) and 8 (0, 29) in oil and control groups. 
All babies were exclusively breastfed and if indicated, were given 
additional nasogastric feeds with expressed breast milk. None of 
the babies received parenteral nutrition during a hospital stay.
At enrollment, 14 babies in oil group and 12 babies in control 
group were symptomatic, most common symptom being a toxic 
appearance in eight neonates in each group. Again, at enrollment 
sepsis screen (defined as abnormal any two of four laboratory 
criteria, viz., total leucocyte count <5000 or >20,000 cells per cubic 
mm, IT ratio >0.2, C-reactive protein >6 mg/L, or abnormal micro 
erythrocyte sedimentation rate) was positive in 19 neonates in each 
group. In oil Group 3 babies had blood culture positive with growth 
of methicillin-resistant coagulase-negative Staphylococcus aureus, 
Enterococcus, and Acinetobacter. In control group organisms were 
Pseudomonas, Acinetobacter, and methicillin-resistant S. aureus 
(two neonates). 19 babies each in oil and control groups received 
antibiotics for treatment of sepsis diagnosed at enrollment.
During the entire study period, all 39 neonates in oil group 
received oil application for a total duration of 388 days while in 
a subgroup of 33 babies receiving oil application for >4 days as 
per protocol schedule total intervention days were 370 (Table 1). 
There were no adverse events of oil application during the study 
period. A total of 36 cultures of stock oil sample done were 
sterile. There was no growth of pathogenic organisms such as 
Escherichia coli, and Klebsiella, on surface cultures of the skin of 
abdomen or axilla in study subjects.
The skin was assessed periodically; with a skin condition 
score of 0 depicting normal skin and gradual deterioration in skin 
condition and with advancing score 9 depicting erythematous, 
crusting, and oozing skin involving entire body surface areas. 
A comparable number of neonates had normal skin with zero 
score at enrollment (oil group=58.9% and control group=66.6%), 
(Table 2). On day 10 of intervention, babies with “normal” skin 
condition were significantly higher in oil group compared to 
control group (p<0.001). Skin condition score kept on improving 
in oil group as duration of hospital stay increased while it 
deteriorated in control group. On day 10 of enrolment, in oil 
group, all the 23 babies had normal skin, and in control group, 
only 1 of 21 babies had normal skin (p<0.001).
Nosocomial sepsis was defined as either positive sepsis screen 
and/or positive blood or cerebrospinal fluid (CSF) culture ≥4 days 
following enrollment. The presence of any clinical feature was an 
indication for sepsis screen and blood culture. 17 babies in oil and 
13 babies in control groups were symptomatic and thus evaluated 
Table 1: Baseline characteristics and intervention for oil and control groups
Baseline variables Oil group (n=39) Control group (n=39)
Age at enrollment (h)
Mean (SD) 16.7 (22.3) 26.3 (29.2)
Median (range) 18 (4,97) 20 (3,102)
Sex female, n (%) 9 (23.1) 13 (33.4)
Gestational age (w), mean (SD) 33 (2.36) 33.5 (2.25)
Enrollment weight (g), mean (SD) 1433 (218) 1520 (277)
Maternal fever, n (%) 6 (15.4) 6 (15.4)
Foul smelling liquor, n (%) 1 (2.5) 1 (2.5)
Frequency/burning micturition (%) 4 (10.2) 2 (5.1)
Prolonged leaking per vaginum n (%) 8 (20.5) 6 (15.3)
Obstetric procedures, n (%) 1 (2.5) 1 (2.5)
Home delivery, n (%) 13 (33.3) 8 (20.5)
Vaginal delivery, n (%) 37 (94.9) 37 (94.9)
Need for resuscitation, n (%) 3 (7.7) 4 (10.2)
Care practice device usage (days)
Median (range) 6 (1,31) 8 (0,29)
Mean (SD) 8.8 (7.25) 9.3 (6.79)
Antibiotics usage at enrollment (n=19) (days) mean (SD) (a) 6.1 (4.13) 8.2 (4.71)
Intervention Intention to treat Per protocol
Duration of oil applications/baby (days) mean (SD) 9.94 (5.8) 11.2 (5.2) (b)
Number of applications/baby mean (SD) 31 (17.6) 34.6 (15.8)
Amount of oil used (ml/baby/application), mean (SD) 6.15 (0.84) 6.21 (0.86)
(a) P=0.039, (b) neonates in control group had routine skin care practices for mean duration of 11.1 days, SD: Standard deviation
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for nosocomial sepsis. Sepsis screen was positive in six subjects 
each, blood culture in two subjects each, and CSF was abnormal in 
one subject each, thus incidence of nosocomial sepsis was 15.4% 
(6/39) and 17.9% (7/39) (p=0.7613) in oil and control groups, 
respectively (14 episodes per 1000 patient days in oil group and 
16 episodes in control group [p=0.4278]). Organisms grown were 
E. coli and Pseudomonas in oil group while in control group 
were E. coli and Enterococcus. No baby had multiple episodes of 
nosocomial infection.
During study period neonates in oil group lost a mean weight of 
41.4 g/kg while babies in control group lost 39.3 g/kg (p=0.8922). The 
mean gain in length and head circumference over study period in oil 
group was 1.47 (1.45) and 0.82 (0.75) cm while in control group was 
1.1 (1.2) cm (p=0.2234) and 0.66 (0.66) cm (p=0.9880), respectively. 
At enrollment, mean serum triglyceride level in oil and control group 
(61 v/s. 57.5 mg/dL) was comparable; however, the mean increase in 
levels during the study period was greater in oil group as compared 
to control group (54.3 v/s. 38.5 mg/dL, p=0.2922).
DISCUSSION
Use of topical cream and its benefits in the improvement of 
neonates’ skin condition have a proven history; many studies 
have compared and shown the skin scores and its effects on the 
skin [9]. The present randomized clinical trial was designed to 
evaluate the effect on nosocomial sepsis of topical application 
of sunflower oil and skin condition in outborn preterm LBW 
neonates. The incidence of nosocomial sepsis in oil group was 
comparable to control group (p=0.4278).
The study conducted by Darmstadt et al. [3] in Egypt 
demonstrated significantly reduced incidence of nosocomial 
infections in sunflower oil group compared to control group (29% 
vs. 47%, p=0.007).
In subsequent year, Darmstadt et al. [11] carried out another 
study in Bangladesh which again revealed the reduced incidence 
of nosocomial sepsis (10.8 episodes/100 patient days in control 
group v/s. 6.95 episodes/100 patient days in sunflower oil 
group). Salam et al. [12] from Pakistan used coconut oil as 
emollient and showed that significantly fewer infants developed 
culture-proven sepsis in the intervention group (39.5 vs. 219.1 
episodes per 1000 patient days). However, the decreased 
incidence of nosocomial sepsis in intervention group as observed 
in all these three studies is in contrast to the observation by 
Edwards et al. [13] who have found increased incidence of 
nosocomial sepsis in prophylactic ointment group, possibly due 
to significantly increased use of care practice devices, including 
assisted ventilation (p=0.04) and systemic antibiotics (p=0.06).
A recent meta-analysis based on some of these trials showed a 
significantly higher incidence of infection in infants treated with 
emollient (total trials=6, n=1551, risk ratio=1:20 [1.01–1.42]) in 
high-income countries whereas in low-income or middle-income 
countries (total trials=2, n=535, and risk ratio=0.91 [0.65–1.28]) 
the incidence of sepsis with or without emollients use was 
comparable [14].
Since the present study has comparable incidence in oil 
and control groups, further analysis of possible confounders 
on nosocomial sepsis was attempted by developing a logistic 
regression model. Risk factors significant on univariable analysis 
were entered into a multiple logistic regression model. The group 
of babies with/without intervention (oil application) was used as 
categorical variable in model. Duration of various care practice 
devices (in days), significant on univariable analysis (mean rank in 
nosocomial sepsis v/s. no nosocomial sepsis group was 71 and 37, 
p=0.0002), was used both as a continuous variable and categorical 
variable (defined as cumulative care practice device usage for 
> vs < 10 days) (Table 3). Skin condition (normal v/s. abnormal) on 
day 10 of enrollment was used as categorical variable. The group of 
babies (nosocomial sepsis v/s. no nosocomial sepsis) was used as 
a dependent variable. On multiple regression analysis, the relative 
risk (95% confidence interval) for care practice device usage, 
when analyzed as continuous variable was 1.189 (1.08–1.298, 
p=0.002) and as categorical variable was 6.193 (4.759–7.627, 
Table 2: Skin condition score
Day of enrollment Skin condition in oil group Skin condition in control group
Normal Abnormal Normal Abnormal
Day 0, n/total (%) 23/39 (58.9) 16/39 (41) 26/39 (66.6) 13/39 (33.3)
Day 5, n/total (%) 32/35 (91.4) 3/35 (8.5) 12/37 (32.4) 25/37 (67.5)
Day 10, n/total (%) 23/23 (100) 0/0 1/21 (4.7) 20/21 (95.2)
Day 15, n/total (%) 12/12 (100) 0/0 0/0 11/11 (100)
Day 20, n/total (%) 5/5 (100) 0/0 0/0 5/5 (100)
Day 25, n/total (%) 0/0 0/0 0/0 2/2 (100)
Table 3: Multivariable regression analysis
Variable Care practice device usage used as continuous 
variable
Care practice device usage used as categorical 
variable
Coefficient B SE OR (95% CI) p Coefficient B SE OR (95% CI) p
Randomization (oil and control) −0.66 0.77 0.52 (−0.10, 2.03) 0.394 −0.79 0.74 0.45 (0.10, 1.90) 0.286
Care practice device usage 0.17 0.06 1.19 (1.08, 1.30) 0.002 1.82 0.73 6.19 (4.76, 7.63) 0.013
Skin condition 0.11 0.54 1.11 (0.05, 2.18) 0.844 −0.34 0.47 0.71 (−0.22, 1.64) 0.475
CI: Confidence interval, OR: Odds ratio, SE: Standard error
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p=0.013). Thus, each additional day of care practice devices usage 
increased the risk of nosocomial sepsis by 1.19 times, despite oil 
application and/or improvement in skin condition.
The strength of present trial is that it is first such study on 
Indian neonates with a trial compliance of 90%. Having small 
sample size and availability of limited information at enrollment 
in outborn neonates for both risk factors of sepsis and antibiotics 
received at referral center are its limitations. Therefore, a 
randomized controlled trial with adequate sample size in neonates 
with lower care practice device usage and antibiotics is suggested 
to evaluate interplay of improved skin condition and breach in its 
integrity on nosocomial sepsis.
CONCLUSIONS
A higher device usage causing breach in integrity of skin and/
or mucous membrane might have nullified the beneficial effect 
of significantly improved neonatal skin condition with oil 
application, thus predisposing these neonates to an increased 
chance of nosocomial sepsis in the presence of a high microbial 
environmental load in developing country.
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